mastheadart
Serving Jersey County Illinois

Custom Search
ADVERTISEMENT
120x600
Today's Health Photos
Tests show no sign of Ebola in Swedish man
Mon, 01 Sep 2014 09:46:42 GMT
STOCKHOLM (Reuters) - Medical authorities in the Swedish capital said on Monday tests on a man brought into hospital over the weekend and suspected of potentially carrying Ebola showed no signs the deadly disease.

BARCELONA (Reuters) - Sales forecasts for Novartis's new heart failure drug are being ramped up by analysts after strikingly good clinical trial results for a medicine doctors expect to transform treatment of the deadly disease.

BARCELONA (Reuters) - A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.

STOCKHOLM (Reuters) - A hospital in the Swedish capital is investigating a possible case of Ebola, Swedish media reported on Sunday.

BARCELONA (Reuters) - The expected launch of Novartis's new heart failure drug next year promises to be the company's most exciting ever and profit margins on the medicine will be good, its head of pharmaceuticals said on Sunday.

BARCELONA (Reuters) - A major clinical study has raised concerns about a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. group Amgen last year.

BARCELONA (Reuters) - An experimental cholesterol-lowering drug from Sanofi and Regeneron Pharmaceuticals roughly halved the number of heart attacks and strokes in a clinical trial, researchers reported on Sunday.

BARCELONA (Reuters) - Swiss engineers, famous for making the world's finest watches, are turning their hands to cardiology with a prototype battery-less pacemaker based on a self-winding wristwatch.

MONROVIA/CONAKRY (Reuters) - Crowds sang and danced in the streets of a seaside neighborhood in Liberia on Saturday as the government lifted quarantine measures designed to contain the spread of the deadly Ebola virus.

BARCELONA (Reuters) - A new medicine from Novartis could replace drugs that have been central to treating heart failure for a quarter of century, after proving remarkably effective in reducing deaths in a keenly awaited study.

Login to access your GTI Webmail Account
Username:@
Password:
 Remember Remember me 
Not a member? Click Here
Browse RSS Feeds
click here when finished
Save Page Layout
Video
ADVERTISEMENT
loading